4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone has been researched along with Eczema, Atopic in 4 studies
4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone: Inhibitor of phosphodiesterases.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, SC | 4 |
| Li, SH | 1 |
| Hanifin, JM | 4 |
| Butler, JM | 1 |
| Ebertz, M | 1 |
| Stevens, SR | 1 |
| Sobieszczuk, D | 1 |
| Cooper, KD | 2 |
| Kang, K | 1 |
4 other studies available for 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone and Eczema, Atopic
| Article | Year |
|---|---|
Increased interleukin-4 production by atopic mononuclear leukocytes correlates with increased cyclic adenosine monophosphate-phosphodiesterase activity and is reversible by phosphodiesterase inhibition.
Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Adult; Cyclic AMP; Dermatitis, Atopic; Humans; Inter | 1993 |
Basophil histamine release in atopic dermatitis and its relationship to disordered cyclic nucleotide metabolism.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Basophils; Carb | 1985 |
Lymphocyte and monocyte localization of altered adrenergic receptors, cAMP responses, and cAMP phosphodiesterase in atopic dermatitis. A possible mechanism for abnormal radiosensitive helper T cells in atopic dermatitis.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; B-Lymphocytes; | 1985 |
Phosphodiesterase inhibition by Ro 20-1724 reduces hyper-IgE synthesis by atopic dermatitis cells in vitro.
Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Adolescent; Adult; Cell Separation; Depression, Chem | 1985 |